OA09306A - "Nouveaux dérivés de la déoxy-2'-uridine substituée en position 5, 3' ou 5' par des groupements x-amino acylés, procédé pour leur obtention et médicaments les contenant". - Google Patents

"Nouveaux dérivés de la déoxy-2'-uridine substituée en position 5, 3' ou 5' par des groupements x-amino acylés, procédé pour leur obtention et médicaments les contenant".

Info

Publication number
OA09306A
OA09306A OA59844A OA59844A OA09306A OA 09306 A OA09306 A OA 09306A OA 59844 A OA59844 A OA 59844A OA 59844 A OA59844 A OA 59844A OA 09306 A OA09306 A OA 09306A
Authority
OA
OAPI
Prior art keywords
radical
pct
deoxy
acylated
production
Prior art date
Application number
OA59844A
Other languages
English (en)
French (fr)
Inventor
Moriniere Jean-Luc
Faulques Michelle
Rousseau Claude
Danree Bernard
Marquer Claude
Saur Patrick
Original Assignee
Inst Rech Chim Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8802255A external-priority patent/FR2627492B1/fr
Priority claimed from FR8808684A external-priority patent/FR2633294B1/fr
Application filed by Inst Rech Chim Biolog filed Critical Inst Rech Chim Biolog
Publication of OA09306A publication Critical patent/OA09306A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA59844A 1988-02-24 1990-08-24 "Nouveaux dérivés de la déoxy-2'-uridine substituée en position 5, 3' ou 5' par des groupements x-amino acylés, procédé pour leur obtention et médicaments les contenant". OA09306A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8802255A FR2627492B1 (fr) 1988-02-24 1988-02-24 Nouveaux derives de l'amino-5(prime)-dideoxy-2(prime)-5(prime)-uridine, procede pour les preparer et compositions pharmaceutiques contenant ces composes
FR8808684A FR2633294B1 (fr) 1988-06-28 1988-06-28 Nouveaux derives de l'amino-3(prime)-dideoxy-2(prime)-3(prime)-uridine, procede pour les preparer et compositions pharmaceutiques contenant ces composes

Publications (1)

Publication Number Publication Date
OA09306A true OA09306A (fr) 1992-09-15

Family

ID=26226515

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59844A OA09306A (fr) 1988-02-24 1990-08-24 "Nouveaux dérivés de la déoxy-2'-uridine substituée en position 5, 3' ou 5' par des groupements x-amino acylés, procédé pour leur obtention et médicaments les contenant".

Country Status (11)

Country Link
US (1) US5212161A (xx)
EP (1) EP0448550B1 (xx)
JP (1) JPH03504492A (xx)
AT (1) ATE109789T1 (xx)
AU (1) AU631119B2 (xx)
DE (1) DE68917479D1 (xx)
DK (1) DK200290A (xx)
FI (1) FI92324C (xx)
NO (1) NO173507C (xx)
OA (1) OA09306A (xx)
WO (1) WO1989008115A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306722A (en) * 1992-09-02 1994-04-26 Bristol-Myers Squibb Company Thymidine derivatives and therapeutic method of use
RU2111970C1 (ru) * 1996-06-25 1998-05-27 Иван Игоревич Федоров 3'-оксимино-2',3'-дидезоксинуклеозиды
JP2001512830A (ja) * 1997-08-08 2001-08-28 ニューバイオティックス インコーポレイテッド 生物療法耐性および化学療法耐性を克服するための方法および組成物
EP1240922B1 (en) * 1997-08-08 2008-11-12 Celmed Oncology (USA), Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
IL137164A0 (en) * 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
BR0012676A (pt) * 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
US20030212037A1 (en) * 2000-12-21 2003-11-13 Christopher Boyer Use of bvdu for inhibiting the growth of hyperproliferative cells
AU2002241911B9 (en) * 2001-01-19 2007-01-25 Celmed Oncology (Usa), Inc. Methods to treat autoimmune and inflammatory conditions
CN1537301A (zh) * 2001-03-16 2004-10-13 G���ع����޹�˾ 在便携式事务处理装置上替换标识数据的系统和方法
WO2003018030A1 (en) * 2001-08-24 2003-03-06 Koronis Pharmaceuticals, Inc. Mutagenic nucleoside analogs for the treatment of viral disease
KR100540509B1 (ko) * 2004-01-07 2006-01-11 학교법인 포항공과대학교 수화젤레이터로 사용되는 2'-데옥시우리딘 유도체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853845A (en) * 1971-08-18 1974-12-10 Icn Pharmaceuticals 5-n-aminoacyl-5-aminouridines
US4093716A (en) * 1977-04-28 1978-06-06 Research Corporation Compositions containing 5-amino-5-deoxythymidine and pharmaceutically acceptable salts thereof
US4128639A (en) * 1977-12-14 1978-12-05 Research Corporation Nitrosourea analogs of thymidine
US4849513A (en) * 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
SE8605503D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel medicinal use
SE8701605D0 (sv) * 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds

Also Published As

Publication number Publication date
ATE109789T1 (de) 1994-08-15
DK200290D0 (da) 1990-08-21
FI92324B (fi) 1994-07-15
NO903704L (no) 1990-10-24
AU3213789A (en) 1989-09-22
WO1989008115A1 (fr) 1989-09-08
US5212161A (en) 1993-05-18
DE68917479D1 (de) 1994-09-15
NO173507B (no) 1993-09-13
NO173507C (no) 1993-12-22
NO903704D0 (no) 1990-08-23
FI92324C (fi) 1994-10-25
EP0448550B1 (fr) 1994-08-10
FI904171A0 (fi) 1990-08-23
EP0448550A1 (fr) 1991-10-02
DK200290A (da) 1990-08-21
AU631119B2 (en) 1992-11-19
JPH03504492A (ja) 1991-10-03

Similar Documents

Publication Publication Date Title
OA09306A (fr) "Nouveaux dérivés de la déoxy-2'-uridine substituée en position 5, 3' ou 5' par des groupements x-amino acylés, procédé pour leur obtention et médicaments les contenant".
RU2458932C2 (ru) N-оксикарбонилзамещенные 5'-деокси-5-фторцитидины и фармацевтический препарат
KR100894167B1 (ko) 신규의 바이러스 증식저해 ·살바이러스방법 및 신규의피라진뉴클레오티드 ·피라진뉴클레오시드 유사체
JP2590248B2 (ja) 抗ウイルス・抗腫瘍・抗転移・免疫系増強ヌクレオシド類およびヌクレオチド類
AU615681B2 (en) Nucleoside derivatives useful in treating retroviral infections
US3755295A (en) 1-(2-amino-2-deoxy-{62 -d-ribofuranosyl) pyrimidines and derivatives thereof
WO1990001036A1 (en) Nucleoside derivatives
JPH01503069A (ja) 新規な医薬化合物
JPH0723314B2 (ja) 治療用ヌクレオシド
JPH01143891A (ja) ビス−アルドアミド類およびそれらを製造する方法
JPH10501809A (ja) 分子内求核置換による公知および新規２′−ヌクレオシドの新規製造方法
CZ291846B6 (cs) Derivát nukleosidmonofosfátu, způsob jeho přípravy a protinádorový prostředek, který ho obsahuje
KR20060008297A (ko) 2'-데옥시-β-Ｌ-뉴클레오시드의 제조방법
FI115215B (fi) Menetelmä oligonukleotidianalogien valmistamiseksi, joista on muodostettu 3'-johdannaisia ja joissa on ei-nukleotidisiä ryhmiä ja niiden käyttö
KR910004198A (ko) 알파 tnf와 반대방향인 대항 메신저 rna의 올리고뉴클레오티드 서열, 그의 제조방법, 약제로서의 용도 및 제약 조성물
JPS638119B2 (xx)
DK170170B1 (da) Alfa-D-Glucopyranosederivater, fremgangsmåde til fremstilling og farmaceutisk komposition med indhold deraf
US5639867A (en) TTTr as protective group in nucleotide synthesis
Bulusu et al. Acyclic analogs of lipid A: synthesis and biological activities.
OA09892A (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
JPH08208686A (ja) アミド主鎖を有するオリゴリボヌクレオチド
EP0330715A1 (en) Disaccharide derivatives
EP0301873B1 (en) 2'-deoxy-5-fluorouridine derivatives
Zhang et al. Synthesis and hybridization property of an oligonucleotide containing a 3′-thioformcetal linked pentathymidylate
CA2092971A1 (en) Amino sugar derivatives